Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Operating Income: 2010-2025

Historic Operating Income for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Sep 2025 value amounting to $98.3 million.

  • Arrowhead Pharmaceuticals' Operating Income rose 127.19% to $44.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.3 million, marking a year-over-year increase of 116.36%. This contributed to the annual value of $98.3 million for FY2025, which is 116.36% up from last year.
  • Arrowhead Pharmaceuticals' Operating Income amounted to $98.3 million in FY2025, which was up 116.36% from -$601.1 million recorded in FY2024.
  • Arrowhead Pharmaceuticals' 5-year Operating Income high stood at $98.3 million for FY2025, and its period low was -$601.1 million during FY2024.
  • For the 3-year period, Arrowhead Pharmaceuticals' Operating Income averaged around -$235.9 million, with its median value being -$205.0 million (2023).
  • As far as peak fluctuations go, Arrowhead Pharmaceuticals' Operating Income tumbled by 193.21% in 2024, and later surged by 116.36% in 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Operating Income (Yearly) stood at -$149.0 million in 2021, then declined by 19.77% to -$178.5 million in 2022, then dropped by 14.84% to -$205.0 million in 2023, then crashed by 193.21% to -$601.1 million in 2024, then spiked by 116.36% to $98.3 million in 2025.